{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:00:05Z","timestamp":1786982405385,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Asociaci\u00f3n Mexicana de Pediatria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Respiratory syncytial virus infection is one of the leading causes of morbidity and mortality in children under two\u00a0years of age. Thus, the objective of this consensus document is to analyze and discuss current scientific evidence and generate recommendations that reflect the position of a prominent national pediatric professional association regarding the benefits and impact of immunoprophylaxis in pregnant women and infants on the burden of respiratory syncytial virus-related respiratory disease in Mexico and Latin America.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Following an academic consensus model, the available scientific literature on current or controversial topics was compiled and critically analyzed. The process adhered to the Guidelines for the Development of Consensus Documents and incorporated recommendations and critical appraisal criteria from the European Appraisal of Guidelines for Research and Evaluation initiative. Multidisciplinary and representative teams were formed from several national professional associations. The studies and manuscripts included in this review were selected via keywords such as respiratory syncytial virus, vaccine, monoclonal antibodies, maternal vaccine, safety and efficacy in vaccine, and vaccine compliance across databases, with priority given to articles published between January 2019 and May 2025. The process included one in-person meeting and one virtual meeting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of nine questions, which were considered unresolved in previous respiratory syncytial virus-related consensus documents, were formulated, covering the time, dose, cost-effectiveness and other perspectives. Each one was addressed through an updated literature review and critical appraisal. The findings and resulting recommendations were presented along with their corresponding level of evidence according to Grading of Recommendations Assessment, Development, and Evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both maternal respiratory syncytial virus vaccination (RSVpreF) and passive immunization with nirsevimab demonstrate robust efficacy and favorable safety, protecting newborns and infants from severe respiratory syncytial virus infections. The document provides actionable, evidence-based recommendations tailored for the Latin American healthcare context, aiming to reduce severe respiratory syncytial virus disease incidence and improve national infant health outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s12519-025-00997-1","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T20:27:50Z","timestamp":1764016070000},"page":"78-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Position statement of the Mexican Association of Pediatrics on the immunoprevention of respiratory syncytial virus infection during pregnancy and infancy"],"prefix":"10.1007","volume":"22","author":[{"given":"Claudia","family":"Montesinos Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Saltigeral Simental","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2534-3108","authenticated-orcid":false,"given":"Federico Javier","family":"Ortiz Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Josefina","family":"Avil\u00e9s Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Adri\u00e1n","family":"Mart\u00ednez Longoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Norberto","family":"Jim\u00e9nez-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Alberto Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigor","family":"Campos Goenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"L\u00f3pez Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Copto Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Diaz L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianey","family":"Escobar Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Carmen Gorbea Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Hernando Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Laurean Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lu\u00e9vanos Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Ortiz-Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Otero Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel Mart\u00edn","family":"Padilla Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Pinacho Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucila","family":"del Carmen S\u00e1nchez Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia F.","family":"Torres Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor Sa\u00fal","family":"Vital Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"997_CR1","unstructured":"World Health Oganization. Virus respiratorio sincitial (VRS). 2025. https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/respiratory-syncytial-virus-(rsv). Accessed 16 May 2025."},{"key":"997_CR2","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399:2047\u201364.","journal-title":"Lancet"},{"key":"997_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/QCO.0000000000000952","volume":"36","author":"APS Munro","year":"2023","unstructured":"Munro APS, Martin\u00f3n-Torres F, Drysdale SB, Faust SN. The disease burden of respiratory syncytial virus in infants. Curr Opin Infect Dis. 2023;36:379\u201384.","journal-title":"Curr Opin Infect Dis"},{"key":"997_CR4","doi-asserted-by":"publisher","first-page":"2381298","DOI":"10.1080\/21645515.2024.2381298","volume":"20","author":"C Moreno","year":"2024","unstructured":"Moreno C, Bardach A, Palermo MC, Sandoval MM, Baumeister E, Ruvinsky S, et al. Economic burden of respiratory syncytial virus disease in Latin America: a systematic review. Hum Vaccin Immunother. 2024;20:2381298.","journal-title":"Hum Vaccin Immunother"},{"key":"997_CR5","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3201\/eid3008.240209","volume":"30","author":"S Goya","year":"2024","unstructured":"Goya S, Ruis C, Neher RA, Meijer A, Aziz A, Hinrichs AS, et al. Standardized phylogenetic classification of human respiratory syncytial virus below the subgroup level. Emerg Infect Dis. 2024;30:1631\u201341.","journal-title":"Emerg Infect Dis"},{"key":"997_CR6","first-page":"e36342","volume":"15","author":"J Kaler","year":"2023","unstructured":"Kaler J, Hussain A, Patel K, Hernandez T, Ray S. Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation. Cureus. 2023;15:e36342.","journal-title":"Cureus"},{"key":"997_CR7","unstructured":"Maternal Immunization-Task Force. Call to action: obstetric care professionals urge recommended vaccines during pregnancy. 2024. https:\/\/www.acog.org\/programs\/immunization-infectious-disease-public-health\/maternal-immunization-task-force\/immunization-for-pregnant-women-a-call-to-action. Accessed 16 May 2025."},{"key":"997_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/infdis\/jiae509","volume":"231","author":"HK Cho","year":"2025","unstructured":"Cho HK, Frivold C, Chu HY. Maternal immunization. J Infect Dis. 2025;231:830\u20136.","journal-title":"J Infect Dis"},{"key":"997_CR9","first-page":"13","volume":"62","author":"R Figueroa Dami\u00e1n","year":"1994","unstructured":"Figueroa Dami\u00e1n R, Ortiz Ibarra FJ, Arredondo Garc\u00eda JL. Profilaxis antirr\u00e1bica postexposici\u00f3n en mujeres gestantes. Ginecol Obstet Mex. 1994;62:13\u20136.","journal-title":"Ginecol Obstet Mex"},{"key":"997_CR10","unstructured":"Gonz\u00e1lez Cort\u00e9s S. Secretar\u00eda de Salud de NL se\u00f1ala baja cobertura de vacunas en embarazadas. Milenio Pol\u00edtica. 2025. Available from: https:\/\/www.milenio.com\/politica\/comunidad\/preocupa-baja-cobertura-de-vacunas-en-embarazadas-en-nuevo-leon. Accessed 16 May 2025 (in Spanish)."},{"key":"997_CR11","unstructured":"Sociedad Latinoamericana de Infectolog\u00eda Pedi\u00e1trica. Virus Respiratorio Sincitial En Am\u00e9rica Latina Y El Caribe Revisi\u00f3n De La Literatura Y Perspectiva Regional Consenso De La Sociedad Latinoamericana De Infectolog\u00eda Pedi\u00e1trica. 2024. https:\/\/slipe.org\/web\/wp-content\/uploads\/2024\/01\/SLIPE-GUIA-VRS-2024.pdf. Accessed 14 May 2025 (in Spanish)."},{"key":"997_CR12","doi-asserted-by":"publisher","first-page":"s6","DOI":"10.35366\/118344","volume":"37","author":"FJ Ortiz Ibarra","year":"2024","unstructured":"Ortiz Ibarra FJ, Gonz\u00e1lez Salda\u00f1a N, Arias de la Garza E, Castillo Bejarano JI, Guti\u00e9rrez Tobar IF, Laris Gonz\u00e1lez A, et al. Consenso de la asociaci\u00f3n mexicana de infectolog\u00eda pedi\u00e1trica (AMIP): prevenci\u00f3n de la infecci\u00f3n por virus sincitial respiratorio en m\u00e9xico, 2024. Rev Latinoam De Infectolog\u00eda Pedi\u00e1trica. 2024;37:s6\u201328 (in Spanish).","journal-title":"Rev Latinoam De Infectolog\u00eda Pedi\u00e1trica"},{"key":"997_CR13","doi-asserted-by":"publisher","first-page":"103183","DOI":"10.1016\/j.arcmed.2025.103183","volume":"56","author":"RM Wong-Chew","year":"2025","unstructured":"Wong-Chew RM, Noyola DE, Sol\u00f3rzano-Santos F, Moreno-Espinosa S, Miranda-Novales MG, Hein EO, et al. Mexican interdisciplinary consensus on the diagnosis and preventive measures for respiratory syncytial virus infections. Arch Med Res. 2025;56:103183.","journal-title":"Arch Med Res"},{"key":"997_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5546\/aap.2012.163","volume":"110","author":"DC Ferrario","year":"2012","unstructured":"Ferrario DC, Califano DG, Dur\u00e1n P, Maccarone DM, Miceli DI, Manterola A, et al. Lineamientos para la elaboraci\u00f3n de Consensos Guidelines for planning consensus Sociedad Argentina de Pediatr\u00eda Subcomisiones, Comit\u00e9s y Grupos de Trabajo. Arch Argent Pediatr. 2012;110:163\u20137 (in Spanish).","journal-title":"Arch Argent Pediatr"},{"key":"997_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/qhc.12.1.18","volume":"12","author":"F Cluzeau","year":"2003","unstructured":"Cluzeau F, Burgers J, Brouwers M, Grol R, M\u00e4kel\u00e4 M, Littlejohns P, et al. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12:18.","journal-title":"Qual Saf Health Care"},{"key":"997_CR16","volume-title":"Reading and preparation of systematic reviews and meta-analysis in the area of health","author":"MF Serv\u00edn Mart\u00ednez","year":"2023","unstructured":"Serv\u00edn Mart\u00ednez MF, Flores Garc\u00eda JA, Parti\u00f1o L\u00f3pez MI, Pierdant P\u00e9rez M. Reading and preparation of systematic reviews and meta-analysis in the area of health. San Luis Potos\u00ed: Autonomous University of San Luis Potos\u00ed; 2023 (in Spanish)."},{"key":"997_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"997_CR18","unstructured":"SINAVE\/DGE. Weekly Report on COVID-19, Influenza, and other Respiratory Viruses, Epidemiological Week 10 of 2025. 2025. https:\/\/www.gob.mx\/salud\/acciones-y-programas\/direccion-general-de-epidemiologia-boletin-epidemiologico. Accessed 14 May 2025 (in Spanish)."},{"key":"997_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijid.2017.06.020","volume":"62","author":"RM Wong-Chew","year":"2017","unstructured":"Wong-Chew RM, Garc\u00eda-Le\u00f3n ML, Noyola DE, Perez Gonzalez LF, Gaitan Meza J, Vilase\u00f1or-Sierra A, et al. Respiratory viruses detected in Mexican children younger than 5 years old with community-acquired pneumonia: a national multicenter study. Int J Infect Dis. 2017;62:32\u20138.","journal-title":"Int J Infect Dis"},{"key":"997_CR20","doi-asserted-by":"publisher","first-page":"E382","DOI":"10.1097\/INF.0000000000004013","volume":"42","author":"LA Esparza-Miranda","year":"2023","unstructured":"Esparza-Miranda LA, Ju\u00e1rez-Tob\u00edas S, Mu\u00f1oz-Escalante JC, Oliva-Jara UA, Cadena-Mota S, Wong-Chew RM, et al. Clinical and epidemiologic characteristics of infants hospitalized with respiratory syncytial virus infection during the 2022\u20132023 season in Mexico. Pediatr Infect Dis J. 2023;42:E382\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"997_CR21","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O\u2019Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modeling study. Lancet. 2017;390:946\u201358.","journal-title":"Lancet"},{"key":"997_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/irv.12606","volume":"13","author":"AA Ortiz-Hern\u00e1ndez","year":"2019","unstructured":"Ortiz-Hern\u00e1ndez AA, Nishimura KK, Noyola DE, Moreno-Espinosa S, Gami\u00f1o A, Galindo-Fraga A, et al. Differential risk of hospitalization among single virus infections causing influenza-like illnesses. Influenza Resp Viruses. 2019;13:36\u201343.","journal-title":"Influenza Resp Viruses"},{"key":"997_CR23","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/INF.0000000000001262","volume":"35","author":"S Vizcarra-Ugalde","year":"2016","unstructured":"Vizcarra-Ugalde S, Rico-Hern\u00e1ndez M, Monjar\u00e1s-\u00c1vila C, Bernal-Silva S, Garrocho-Rangel ME, Ochoa-P\u00e9rez UR, et al. Intensive care unit admission and death rates of infants admitted with respiratory syncytial virus lower respiratory tract infection in Mexico. Pediatr Infect Dis J. 2016;35:1199\u2013203.","journal-title":"Pediatr Infect Dis J"},{"key":"997_CR24","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","volume":"388","author":"B Kampmann","year":"2023","unstructured":"Kampmann B, Madhi SA, Munjal I, Sim\u00f5es EAF, Pahud BA, Llapur C, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023;388:1451\u201364.","journal-title":"N Engl J Med"},{"key":"997_CR25","doi-asserted-by":"crossref","unstructured":"Razzini JL, Parada D, Solovey G, Gui\u00f1az\u00fa G, Sosa EM, Esposto S, et al. Impact and effectiveness of universal respiratory syncytial virus vaccination during pregnancy on infant hospitalizations in Buenos Aires: a retrospective cohort study. 2025. https:\/\/verixiv.org\/articles\/2-34\/v1. Accessed 16 May 2025.","DOI":"10.12688\/verixiv.786.1"},{"key":"997_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/AOG.0000000000005816","volume":"145","author":"EAF Sim\u00f5es","year":"2025","unstructured":"Sim\u00f5es EAF, Pahud BA, Madhi SA, Kampmann B, Shittu E, Radley D, et al. Efficacy, safety, and immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial. Obstet Gynecol. 2025;145:157\u201367.","journal-title":"Obstet Gynecol"},{"key":"997_CR27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1473-3099(25)00156-2","volume":"25","author":"G P\u00e9rez Marc","year":"2025","unstructured":"P\u00e9rez Marc G, Vizzotti C, Fell DB, Di Nunzio L, Olszevicki S, Mankiewicz SW, et al. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case\u2013control study. Lancet Infect Dis. 2025;25:1044\u201354.","journal-title":"Lancet Infect Dis"},{"key":"997_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/AOG.0000000000005817","volume":"145","author":"SA Madhi","year":"2025","unstructured":"Madhi SA, Kampmann B, Sim\u00f5es EAF, Zachariah P, Pahud BA, Radley D, et al. Preterm birth frequency and associated outcomes from the MATISSE (maternal immunization study for safety and efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine. Obstet Gynecol. 2025;145:147.","journal-title":"Obstet Gynecol"},{"key":"997_CR29","unstructured":"CDC ACIP. ACIP evidence to recommendations for use of nirsevimab in infants born during the RSV season or entering their first RSV season. 2024. https:\/\/www.cdc.gov\/acip\/evidence-to-recommendations\/nirsevimab-season1-rsv-infants-children-etr.html. Accessed 15 April 2025."},{"key":"997_CR30","unstructured":"European Medicines Agency (EMA). First RSV vaccine to protect infants up to 6 months of age and older adults. 2023. https:\/\/www.ema.europa.eu\/en\/news\/first-rsv-vaccine-protect-infants-6-months-age-and-older-adults. Accessed 16 May 2025."},{"key":"997_CR31","unstructured":"WHO. WHO outlines recommendations to protect infants against RSV. 2025. https:\/\/www.who.int\/news\/item\/30-05-2025-who-outlines-recommendations-to-protect-infants-against-rsv-respiratory-syncytial-virus. Accessed 4 Sept 2025."},{"key":"997_CR32","unstructured":"FDA, Cber. May 31, 2023 Summary basis for regulatory action\u2014ABRYSVO. 2023. https:\/\/www.fda.gov\/media\/169721\/download?attachment. Accessed 15 April 2025."},{"key":"997_CR33","unstructured":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (COFEPRIS). Cofepris autoriza vacunas contra Virus Sincicial Respiratorio (VSR) para aplicar a mujeres embarazadas y adultos mayores. 2024. https:\/\/www.gob.mx\/cofepris\/es\/articulos\/cofepris-autoriza-vacunas-contra-virus-sincicial-respiratorio-vsr-para-aplicar-a-mujeres-embarazadas-y-adultos-mayores-386366?idiom=es. Accessed 16 May 2025."},{"key":"997_CR34","doi-asserted-by":"publisher","first-page":"985646","DOI":"10.1155\/2012\/985646","volume":"2012","author":"P Palmeira","year":"2012","unstructured":"Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012;2012:985646.","journal-title":"Clin Dev Immunol"},{"key":"997_CR35","doi-asserted-by":"publisher","first-page":"7567708","DOI":"10.1155\/2022\/7567708","volume":"2022","author":"T Hussain","year":"2022","unstructured":"Hussain T, Murtaza G, Kalhoro DH, Kalhoro MS, Yin Y, Chughtai MI, et al. Understanding the immune system in fetal protection and maternal infections during pregnancy. J Immunol Res. 2022;2022:7567708.","journal-title":"J Immunol Res"},{"key":"997_CR36","doi-asserted-by":"publisher","first-page":"12048","DOI":"10.1073\/pnas.1304718110","volume":"110","author":"E Delorme-Axford","year":"2013","unstructured":"Delorme-Axford E, Donker RB, Mouillet JF, Chu T, Bayer A, Ouyang Y, et al. Human placental trophoblasts confer viral resistance to recipient cells. Proc Natl Acad Sci USA. 2013;110:12048\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"997_CR37","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3389\/fimmu.2018.01548","volume":"9","author":"CR Wilcox","year":"2018","unstructured":"Wilcox CR, Jones CE. Beyond passive immunity: is there priming of the fetal immune system following vaccination in pregnancy and what are the potential clinical implications? Front Immunol. 2018;9:1548.","journal-title":"Front Immunol"},{"key":"997_CR38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00112-021-01321-7","volume":"169","author":"M R\u00f6bl-Mathieu","year":"2021","unstructured":"R\u00f6bl-Mathieu M, Terhardt M. Vaccination during pregnancy. Monatsschr Kinderheilkd. 2021;169:1043\u201350 (in German).","journal-title":"Monatsschr Kinderheilkd"},{"key":"997_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/diagnostics10080583","volume":"10","author":"AM Ciobanu","year":"2020","unstructured":"Ciobanu AM, Dumitru AE, Gica N, Botezatu R, Peltecu G, Panaitescu AM. Benefits and risks of IgG transplacental transfer. Diagnostics (Basel). 2020;10:583.","journal-title":"Diagnostics (Basel)"},{"key":"997_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/10408444.2011.653487","volume":"42","author":"JM Desesso","year":"2012","unstructured":"Desesso JM, Williams AL, Ahuja A, Bowman CJ, Hurtt ME. The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy. Crit Rev Toxicol. 2012;42:185\u2013210.","journal-title":"Crit Rev Toxicol"},{"key":"997_CR41","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez Alde\u00e1n J, \u00c1lvarez Garc\u00eda FJ, de la Calle Fern\u00e1ndez-Miranda M, Figueras Falc\u00f3n T, Iofr\u00edo de Arce A, Rojano ML, et al. Vaccination in pregnancy. Consensus document of the CAV-AEP and the SEGO. An Pediatr (Engl Ed). 2024;100:268\u201374.","DOI":"10.1016\/j.anpede.2024.02.014"},{"key":"997_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/infdis\/jiad024","volume":"228","author":"Z Bebia","year":"2023","unstructured":"Bebia Z, Reyes O, Jeanfreau R, Kantele A, De Leon RG, S\u00e1nchez MG, et al. Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial. J Infect Dis. 2023;228:299\u2013310.","journal-title":"J Infect Dis"},{"key":"997_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000536031","volume":"121","author":"MP Mapindra","year":"2024","unstructured":"Mapindra MP, Mahindra MP, McNamara P, Semple MG, Clark H, Madsen J. Respiratory syncytial virus maternal vaccination in infants below 6 months of age: meta-analysis of safety, immunogenicity, and efficacy. Neonatology. 2024;121:271\u201382.","journal-title":"Neonatology"},{"key":"997_CR44","unstructured":"Ministerio de Salud Republica de Argentina. Quick Guide: Vaccine against Respiratory Syncytial Virus in Pregnant Persons. 2018. https:\/\/www.argentina.gob.ar\/sites\/default\/files\/2018\/02\/guia_rapida_vsr.pdf. Accessed 17 May 2025 (in Spanish)."},{"key":"997_CR45","unstructured":"Secretaria de Salud. Manual of Events Supposedly Attributable to Vaccination or Immunization. Centro Nacional para la Salud de la Infancia y Adolescencia Gobierno de M\u00e9xico. 2015. Available from: https:\/\/www.gob.mx\/salud%7Ccensia\/documentos\/manual-de-eventos-supuestamente-atribuibles-a-la-vacunacion-o-inmunizacion-esavi. Accessed 17 May 2025 (in Spanish)."},{"key":"997_CR46","unstructured":"UK Health Security Agency. Respiratory syncytial virus: the green book, chapter 27a. Gov UK. 2013. https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-the-green-book-chapter-27a. Accessed 17 May 2025."},{"key":"997_CR47","unstructured":"Centers for Disease Control and Prevention (CDC). Immunizations to protect infants. 2024. https:\/\/www.cdc.gov\/rsv\/vaccines\/protect-infants.html. Accessed 17 May 2025."},{"key":"997_CR48","unstructured":"CAV-AEP. Coadministraci\u00f3n de las vacunas entre s\u00ed y con otros productos biol\u00f3gicos. Online Immunization Manual of the Spanish Association of Pediatrics (AEP). 2025. https:\/\/vacunasaep.org\/documentos\/manual\/cap-2. Accessed 18 Aug 2024 (in Spanish)."},{"key":"997_CR49","unstructured":"UK Health Security Agency. A guide to RSV vaccination for pregnant women\u2014GOV.UK. GOV.UK. 2025. https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-rsv-maternal-vaccination\/a-guide-to-rsv-vaccination-for-pregnant-women. Accessed 17 May 2025."},{"key":"997_CR50","unstructured":"Organizaci\u00f3n Panamericana de la Salud. PAHO to facilitate Access to maternal vaccines to protect babies in the Americas from respiratory syncytial virus. OPS\/OMS. 2024. https:\/\/www.paho.org\/es\/noticias\/1-11-2024-ops-facilitara-acceso-vacunas-maternas-para-proteger-bebes-americas-virus. Accessed 17 May 2025 (in Spanish)."},{"key":"997_CR51","unstructured":"Ministerio de Salud. Vaccination campaign beigs against respiratory syncytial virus. Argentina.gob.ar. 2025. https:\/\/www.argentina.gob.ar\/noticias\/se-inicia-la-vacunacion-contra-virus-sincicial-respiratorio. Accessed 17 May 2025 (in Spanish)."},{"key":"997_CR52","unstructured":"Ministerio de Salud P\u00fablica. Vaccination against the Respiratory Syncytial Virus (RSV) 2025 Campaign. 2025. https:\/\/www.gub.uy\/ministerio-salud-publica\/comunicacion\/publicaciones\/vacunacion-contra-virus-respiratorio-sincitial-vrs-documento-tecnico. Accessed 17 May 2025 (in Spanish)."},{"key":"997_CR53","unstructured":"Ministerio de Salud Costa Rica. Vacunar\u00e1n embarazadas contra virus sincicial. 2024. https:\/\/www.ministeriodesalud.go.cr\/index.php\/prensa\/61-noticias-2024\/1996-vacunaran-embarazadas-contra-virus-sincicial. Accessed 17 May 2025 (in Spanish)."},{"key":"997_CR54","unstructured":"Mena M. Vacuna contra el virus sincicial: aprobaci\u00f3n en Costa Rica. El Observador. 2024. https:\/\/observador.cr\/salud-aplicara-vacuna-contra-el-virus-sincicial-a-embarazadas-en-costa-rica-a-partir-del-2025\/. Accessed 17 May 2025."},{"key":"997_CR55","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1097\/AOG.0000000000005492","volume":"143","author":"H Debessai","year":"2024","unstructured":"Debessai H, Jones JM, Meaney-Delman D, Rasmussen SA. What U.S. obstetricians need to know about respiratory syncytial virus. Obstet Gynecol. 2024;143:E54\u201362.","journal-title":"Obstet Gynecol"},{"key":"997_CR56","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","volume":"72","author":"KE Fleming-Dutra","year":"2023","unstructured":"Fleming-Dutra KE, Jones JM, Roper LE, Prill MM, Ortega-Sanchez IR, Moulia DL, et al. Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:1115\u201322.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"997_CR57","doi-asserted-by":"publisher","first-page":"B41","DOI":"10.1016\/j.ajog.2023.10.046","volume":"230","author":"NT Joseph","year":"2024","unstructured":"Joseph NT, Kuller JA, Louis JM, Hughes BL. Society for Maternal-Fetal Medicine Statement: clinical considerations for the prevention of respiratory syncytial virus disease in infants. Am J Obstet Gynecol. 2024;230:B41\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"997_CR58","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","volume":"386","author":"LL Hammitt","year":"2022","unstructured":"Hammitt LL, Dagan R, Yuan Y, Cots MB, Bosheva M, Madhi SA, et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386:837\u201346.","journal-title":"N Engl J Med"},{"key":"997_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","volume":"7","author":"EAF Sim\u00f5es","year":"2023","unstructured":"Sim\u00f5es EAF, Madhi SA, Muller WJ, Atanasova V, Bosheva M, Caba\u00f1as F, et al. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. Lancet Child Adolesc Health. 2023;7:180\u20139.","journal-title":"Lancet Child Adolesc Health"},{"key":"997_CR60","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","volume":"389","author":"SB Drysdale","year":"2023","unstructured":"Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC, et al. Nirsevimab for prevention of hospitalizations due to RSV in infants. N Engl J Med. 2023;389:2425\u201335.","journal-title":"N Engl J Med"},{"key":"997_CR61","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJMc2112186","volume":"386","author":"J Domachowske","year":"2022","unstructured":"Domachowske J, Madhi SA, Sim\u00f5es EAF, Atanasova V, Caba\u00f1as F, Furuno K, et al. Safety of nirsevimab for RSV in infants with heart or lung disease or prematurity. NEJM. 2022;386:892\u20134.","journal-title":"NEJM"},{"key":"997_CR62","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S2352-4642(25)00102-6","volume":"9","author":"APS Munro","year":"2025","unstructured":"Munro APS, Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, et al. 180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial. Lancet Child Adolesc Health. 2025;9:404\u201312.","journal-title":"Lancet Child Adolesc Health"},{"key":"997_CR63","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1473-3099(24)00215-9","volume":"24","author":"S Ares-G\u00f3mez","year":"2024","unstructured":"Ares-G\u00f3mez S, Mallah N, Santiago-P\u00e9rez MI, Pardo-Seco J, P\u00e9rez-Mart\u00ednez O, Otero-Barr\u00f3s MT, et al. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. Lancet Infect Dis. 2024;24:817\u201328.","journal-title":"Lancet Infect Dis"},{"key":"997_CR64","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/archdischild-2024-327153","volume":"109","author":"E Coma","year":"2024","unstructured":"Coma E, Martinez-Marcos M, Hermosilla E, Mendioroz J, Re\u00f1\u00e9 A, Fina F, et al. Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain). Arch Dis Child. 2024;109:736\u201341.","journal-title":"Arch Dis Child"},{"key":"997_CR65","doi-asserted-by":"publisher","first-page":"e13294","DOI":"10.1111\/irv.13294","volume":"18","author":"C Mazagatos","year":"2024","unstructured":"Mazagatos C, Mendioroz J, Rumayor MB, Gallardo Garc\u00eda V, \u00c1lvarez R\u00edo V, Cebollada Gracia AD, et al. Estimated impact of nirsevimab on the incidence of respiratory syncytial virus infections requiring hospital admission in children < 1 year, weeks 40, 2023, to 8, 2024, Spain. Influenza Other Respir Viruses. 2024;18:e13294.","journal-title":"Influenza Other Respir Viruses"},{"key":"997_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.15585\/mmwr.mm7309a4","volume":"73","author":"HL Moline","year":"2024","unstructured":"Moline HL, Tannis A, Toepfer AP, Williams JV, Boom JA, Englund JA, et al. Early estimate of nirsevimab effectiveness for prevention of respiratory syncytial virus-associated hospitalization among infants entering their first respiratory syncytial virus season\u2014New Vaccine Surveillance Network, October 2023\u2013February 2024. MMWR Morb Mortal Wkly Rep. 2024;73:209\u201314.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"997_CR67","doi-asserted-by":"publisher","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","volume":"74","author":"DL Moulia","year":"2025","unstructured":"Moulia DL, Link-Gelles R, Chu HY, Jamieson D, Brooks O, Meyer S, et al. Use of clesrovimab for prevention of severe respiratory syncytial virus-associated lower respiratory tract infections in infants: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2025. MMWR Morb Mortal Wkly Rep. 2025;74:508\u201314.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"997_CR68","unstructured":"ACIP. ACIP Evidence to recommendations for use of clesrovimab in infants age. 2025. https:\/\/www.cdc.gov\/acip\/evidence-to-recommendations\/clesrovimab-infants.html. Accessed 4 Sept 2025."},{"key":"997_CR69","unstructured":"Ernst D. RSV prevention therapy palivizumab to be discontinued. 2025. https:\/\/www.vaccineadvisor.com\/news\/rsv-prevention-therapy-palivizumab-to-be-discontinued\/. Accessed 4 Sept 2025."},{"key":"997_CR70","unstructured":"Centers for Disease Control and Prevention (CDC). RSV Vaccine Guidance for Pregnant Women. U.S. Department of Health & Human Services. 2023. https:\/\/www.cdc.gov\/rsv\/hcp\/vaccine-clinical-guidance\/pregnant-people.html. Accessed 17 May 2025."},{"key":"997_CR71","unstructured":"American College of Obstetricians and Gynecologists (ACOG), Hughes BrennaL, Riley LauraE. Maternal respiratory syncytial virus vaccination. ACOG Clinical. 2023. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2023\/09\/maternal-respiratory-syncytial-virus-vaccination. Accessed 17 May 2025."},{"key":"997_CR72","unstructured":"ClinicalTrials.gov. A phase 3 study of revaccination in subsequent pregnancies with Bivalent RSV vaccine and duration of protection of a single dose. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06866405?cond=RSV%20&rank=10. Accessed 2 Sept 2025."},{"key":"997_CR73","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ajic.2020.04.009","volume":"48","author":"A Comas-Garc\u00eda","year":"2020","unstructured":"Comas-Garc\u00eda A, Aguilera-Mart\u00ednez JI, Escalante-Padr\u00f3n FJ, Lima-Rogel V, Gutierrez-Mendoza LM, Noyola DE. Clinical impact and direct costs of nosocomial respiratory syncytial virus infections in the neonatal intensive care unit. Am J Infect Control. 2020;48:982\u20136.","journal-title":"Am J Infect Control"},{"key":"997_CR74","unstructured":"World Health Organization (WHO). WHO position paper on immunization to protect infants against respiratory syncytial virus disease. 2025. https:\/\/www.who.int\/publications\/i\/item\/WER10022. Accessed 30 May 2025."}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-025-00997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-025-00997-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-025-00997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:02:44Z","timestamp":1770836564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-025-00997-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1007\/s12519-025-00997-1","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors received expenses funding from the Mexican Association of Pediatrics (AMP) for their contribution to this position statement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. This position statement is based on a review of existing literature and expert consensus, and did not involve human participants, human data, or animal research requiring ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}